These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7915057)

  • 1. Progress in monoclonal antibodies in clinical transplantation.
    Cosimi AB
    Transplant Proc; 1994 Aug; 26(4):1943-4. PubMed ID: 7915057
    [No Abstract]   [Full Text] [Related]  

  • 2. [The immunobiology of transplant rejection and its pharmacological modification].
    Köhler H; Zanker B; Strom TB
    Dtsch Med Wochenschr; 1991 Feb; 116(7):264-9. PubMed ID: 1825196
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of monoclonal antibodies on primate allograft rejection.
    Conti DJ; Cosimi AB
    Crit Rev Immunol; 1990; 10(2):113-30. PubMed ID: 1981679
    [No Abstract]   [Full Text] [Related]  

  • 4. New immunosuppressive therapies in renal transplantation: monoclonal antibodies.
    Buhaescu I; Segall L; Goldsmith D; Covic A
    J Nephrol; 2005; 18(5):529-36. PubMed ID: 16299678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical application of monoclonal antibody therapies in renal transplantation.
    Dhanireddy KK; Xu H; Mannon RB; Hale DA; Kirk AD
    Expert Opin Emerg Drugs; 2004 May; 9(1):23-37. PubMed ID: 15155134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with a new monoclonal antibody in clinical kidney transplantation.
    Hillebrand G; Rothaug E; Hammer C; Illner WD; Schleibner S; Racenberg J; Gurland HJ; Land W
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1776-7. PubMed ID: 2652581
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcome of lymphocyte subsets and cytokines during combined CD4/anti-IL-2R monoclonal antibody therapy in kidney transplantation.
    Racadot E; Mousson C; Tanter Y; Wijdenes J; Rifle G; Herve P
    Transplant Proc; 1995 Apr; 27(2):1672-3. PubMed ID: 7536975
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological reagents for immunosuppressants.
    Soulillou JP
    Transplant Proc; 1995 Feb; 27(1):106-8. PubMed ID: 7878803
    [No Abstract]   [Full Text] [Related]  

  • 9. Nonhuman primate response to murine and humanized monoclonal antibodies.
    Delmonico FL; Cosimi AB
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):65-7. PubMed ID: 8096663
    [No Abstract]   [Full Text] [Related]  

  • 10. The potential role of therapeutic antibodies in the regulation of rejection.
    Ettenger RB; Yadin O
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):13-7. PubMed ID: 7482810
    [No Abstract]   [Full Text] [Related]  

  • 11. T-lymphocyte adhesion and immunointervention in transplantation.
    Fischer A
    Adv Nephrol Necker Hosp; 1991; 20():305-11. PubMed ID: 2063719
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4.
    Jendrisak M; Jendrisak G; Gamero J; Mohanakumar T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):825-7. PubMed ID: 8094914
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction in cellular and vascular rejection by blocking leukocyte adhesion molecule receptors.
    Sadahiro M; McDonald TO; Allen MD
    Am J Pathol; 1993 Mar; 142(3):675-83. PubMed ID: 8096120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunosuppressive action of anti-CD18 monoclonal antibody in rat heterotopic heart allotransplantation.
    Kameoka H; Ishibashi M; Tamatani T; Takano Y; Moutabarrik A; Jiang H; Kokado Y; Takahara S; Okuyama A; Kinoshita T
    Transplantation; 1993 Mar; 55(3):665-7. PubMed ID: 8096101
    [No Abstract]   [Full Text] [Related]  

  • 15. BT563 significantly decreases sIL-2R plasma levels despite acute allograft rejection.
    Mueller AR; Platz KP; Steinmüller T; Nüssler N; Neumann U; Gerlach H; Stoll C; Bechstein WO; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3103-5. PubMed ID: 8962203
    [No Abstract]   [Full Text] [Related]  

  • 16. Understanding the structural basis of T-cell costimulation.
    Bajorath J
    J Mol Graph Model; 2000 Apr; 18(2):176-9. PubMed ID: 10994522
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro system for evaluation of the immunomodulatory capacity of CD45(R) reagents.
    Poppema S; Visser L; Jiang XY
    Transplant Proc; 1996 Dec; 28(6):3263-4. PubMed ID: 8962266
    [No Abstract]   [Full Text] [Related]  

  • 18. Clonal anergy induction by monoclonal antibodies to CD4, LFA-1, and ICAM-1.
    Jendrisak G; Gamero J; Mohanakumar T; Jendrisak M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):828-30. PubMed ID: 8094915
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of a chimeric interleukin-2 receptor monoclonal antibody, basiliximab, in renal transplantation: a comparison between Japanese and non-Japanese patients.
    Haba T; Uchida K; Katayama A; Tominaga Y; Sato T; Watanabe I; Inagaki H; Kimata T; Goto K; Morozumi K; Takeda A; Takahara S; Takahashi K; Oshima S
    Transplant Proc; 2001; 33(7-8):3174-5. PubMed ID: 11750362
    [No Abstract]   [Full Text] [Related]  

  • 20. Flow cytometry analysis of increased expression of LFA-1/ICAM-1 in TCR-positive lymphocytes infiltrating cardiac allografts in rats.
    Tsuchida M; Hirahara H; Hirono T; Hanawa H; Matsumoto Y; Abo T; Eguchi S
    Transplant Proc; 1994 Dec; 26(6):3727-30. PubMed ID: 7998330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.